What is the official ID of this bill?
The official print number for this legislation is S 1961.
Pharmaceutical Supply Chain Risk Assessment: Ensuring Drug Availability and National Security.
This Act mandates a comprehensive government assessment of the pharmaceutical supply chain to prevent drug shortages and protect public health. The goal is to identify essential medicines with vulnerable supply chains, especially those sourced internationally, and strengthen domestic manufacturing capabilities. This measure aims to ensure citizens have stable access to critical medications during emergencies and daily life.
Key points
The government must create a list of essential medicines and annually assess which ones have the most vulnerable supply chains, particularly those manufactured abroad.
The assessment will identify gaps in domestic drug production and threats, including cyberattacks, that could disrupt life-saving supplies.
The findings of the assessment, excluding sensitive information, will be made publicly available, increasing transparency regarding drug supply security.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.